New drugs for ovarian cancer

Ann Oncol. 2011 Dec:22 Suppl 8:viii77-viii82. doi: 10.1093/annonc/mdr531.
No abstract available

Publication types

  • Review

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use
  • Antibodies, Monoclonal / therapeutic use
  • Antineoplastic Agents / therapeutic use*
  • Clinical Trials, Phase II as Topic
  • Female
  • Humans
  • Ovarian Neoplasms / drug therapy*
  • Poly(ADP-ribose) Polymerase Inhibitors
  • Randomized Controlled Trials as Topic
  • Treatment Outcome

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Poly(ADP-ribose) Polymerase Inhibitors